​

Editas Medicine Ownership | Who Owns Editas Medicine?

OverviewForecastRevenueFinancialsChartTranscripts

Editas Medicine Ownership Summary

Editas Medicine is owned by 66.85% institutional investors, 0.32% insiders, and 32.83% retail investors. Vanguard group is the largest institutional shareholder, holding 9.80% of EDIT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Editas Medicine shares.

EDIT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEditas Medicine66.85%0.32%32.83%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group8.03M9.80%$37.51M
Blackrock7.78M9.50%$36.34M
Deep track capital, lp6.00M7.32%$28.02M
State street4.59M5.60%$21.44M
Millennium management2.46M3.00%$11.49M
Dimensional fund advisors lp2.35M2.86%$10.95M
Geode capital management1.97M2.40%$9.18M
Pictet asset management sa1.43M1.74%$6.67M
Goldman sachs group1.22M1.49%$5.69M
Woodline partners lp970.49K1.18%$4.53M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Deep track capital, lp6.00M0.84%$28.02M
Knott david m jr177.00K0.33%$827.00K
Avidity partners management lp816.00K0.16%$3.81M
Green alpha advisors30.27K0.11%$141.35K
Pdt partners246.54K0.11%$1.15M
Woodline partners lp970.49K0.04%$4.53M
Hennion & walsh asset management168.37K0.04%$786.29K
Virtus etf advisers16.49K0.04%$77.00K
Dlk investment management17.70K0.03%$82.67K
Trexquant investment lp472.71K0.03%$2.21M

Top Buyers

HolderShares% AssetsChange
Ubs asset management americas901.62K0.00%818.06K
Avidity partners management lp816.00K0.16%816.00K
Deep track capital, lp6.00M0.84%472.71K
Hrt financial lp298.03K0.01%298.03K
Trexquant investment lp472.71K0.03%273.51K

Top Sellers

HolderShares% AssetsChange
State street4.59M0.00%-4.17M
Qube research---1.05M
Morgan stanley918.23K0.00%-865.50K
Two sigma investments, lp540.59K0.01%-847.39K
Pictet asset management sa1.43M0.01%-834.37K

New Positions

HolderShares% AssetsChangeValue
Avidity partners management lp816.00K0.16%816.00K$3.81M
Mirae asset global etfs205.14K0.00%205.14K$958.56K
Hennion & walsh asset management168.37K0.04%168.37K$786.29K
Toroso investments117.44K0.01%117.44K$548.42K
Thrivent financial for lutherans85.78K0.00%85.78K$400.00K

Sold Out

HolderChange
Pacific capital wealth advisors-5.00
Sittner & nelson-6.00
Baldwin brothers llc/ma-8.00
Farther finance advisors-10.00
Optiver b.v.-11.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024234-2.50%55,137,509-2.17%661.43%100-10.71%64-12.33%
Jun 30, 20242382.15%56,360,093-17.01%680.86%111-7116.39%
Mar 31, 20242330.87%67,911,28916.06%891.74%11116.84%61-12.86%
Dec 31, 20232311.32%58,514,008-4.86%710.97%95-5.94%7011.11%
Sep 30, 2023228-8.06%61,505,743-1.82%861.04%101-13.68%6331.25%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.59M3.14%-
iShares Russell 2000 ETF2.15M2.61%-4.84K
Vanguard Institutional Extnd Mkt Idx Tr1.35M1.64%-6.34K
Vanguard Strategic Equity Inv1.19M1.44%-
Pictet Biopharmaceutical Mother1.10M1.34%182.83K
Vanguard Small Cap Index1.04M1.26%2.50K
Fidelity Small Cap Index850.45K1.03%-17.82K
iShares Russell 2000 Value ETF784.49K0.95%-
UBS (Lux) Digital Health Equity SB USD750.00K0.91%-
JPM Thematics Genetic Thrps C2 Acc USD696.63K0.84%-28.69K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 03, 2024O'Neill Gilmore Neil CEOSell$3.36K
Dec 03, 2024Mei Baisong EVP, CHIEF MEDICAL OFFICERSell$1.12K
Sep 04, 2024Mei Baisong EVP, CHIEF MEDICAL OFFICERSell$1.77K
Sep 04, 2024O'Neill Gilmore Neil CEOSell$5.33K
Jul 25, 2024Burkly Linda EVP, CHIEF SCIENTIFIC OFFICERSell$64.37K

Insider Transactions Trends

DateBuySell
2024 Q4-2
2024 Q3-4
2024 Q213
2024 Q1-2
2023 Q4-3

EDIT Ownership FAQ

Who Owns Editas Medicine?

Editas Medicine shareholders are primarily institutional investors at 66.85%, followed by 0.32% insiders and 32.83% retail investors. The average institutional ownership in Editas Medicine's industry, Biotech Stocks , is 47.04%, which Editas Medicine exceeds.

Who owns the most shares of Editas Medicine?

Editas Medicine’s largest shareholders are Vanguard group (8.03M shares, 9.80%), Blackrock (7.78M shares, 9.50%), and Deep track capital, lp (6M shares, 7.32%). Together, they hold 26.62% of Editas Medicine’s total shares outstanding.

Does Blackrock own Editas Medicine?

Yes, BlackRock owns 9.50% of Editas Medicine, totaling 7.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.34M$. In the last quarter, BlackRock decreased its holdings by -50.264K shares, a -0.64% change.

Who is Editas Medicine’s biggest shareholder by percentage of total assets invested?

Deep track capital, lp is Editas Medicine’s biggest shareholder by percentage of total assets invested, with 0.84% of its assets in 6M Editas Medicine shares, valued at 28.02M$.

Who is the top mutual fund holder of Editas Medicine shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Editas Medicine shares, with 3.14% of its total shares outstanding invested in 2.59M Editas Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools